Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic and Prognostic Significance of Complement in Patients With Alcohol‐Associated Hepatitis

17 Jun 2020

Abstract excerpt

BACKGROUND AND AIMS: Given the lack of effective therapies and high mortality in acute alcohol-associated hepatitis (AH), it is important to develop rationally designed biomarkers for effective disease management. Complement, a critical component of the innate immune system, contributes to uncontrolled inflammatory responses leading to liver injury, but is also involved in hepatic regeneration. Here, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcohol Consumption and Health Effects
Share to Complement system in diseases
Share to Liver Disease and Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32557728
DOI: 10.1002/hep.31419

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and Prognostic Significance of Complement in Patients With Alcohol‐Associated HepatitisPMID 32557728Read ↗

Causal Association between Circulating Complement Components and Non-Viral Liver Diseases and Their Potential as Therapeutic Targets: An Integrated Analysis Based on Multi-omics DataSemantic proximity Read ↗

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targetsSemantic proximity Read ↗

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19Semantic proximity Read ↗

Complement dysregulation is a predictive and therapeutically amenable feature of long COVIDSemantic proximity Read ↗

Early Identification of At-Risk Patients: Proteomic Signature Predicts Progression to Decompensated CirrhosisSemantic proximity Read ↗

The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinomaSemantic proximity Read ↗

Role of complement component C4 in treatment response and disease progression in chronic hepatitis C patients.Semantic proximity Read ↗

Significance of complement split product C4d in ABO-compatible liver allograft: Diagnosing utility in acute antibody mediated rejectionSemantic proximity Read ↗

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4Semantic proximity Read ↗

Immunopathology of terminal complement activation and complement C5 blockade creating a pro-survival and organ-protective phenotype in trauma.Semantic proximity Read ↗

Two sides of a coin: GG genotype of C7 provides protection against fibrosis severity while showing a higher risk for hepatocellular carcinoma in patients with hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.